Postoperative hyperfractionated IMRT with weekly cisplatin for head and neck cancer: phase IIa trial
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Radiation Research"
DOI: 10.1093/jrr/rraf006
Abstract: Abstract Postoperative chemoradiotherapy (POCRT) is the standard treatment for patients with head and neck squamous cell carcinoma (HNSCC) with high-risk features (positive microscopic margins and/or extranodal extensions). We hypothesized that dose escalation using hyperfractionation in… read more here.
Keywords: proportion patients; treatment; patients completed; cisplatin ... See more keywords
Phase I study of induction chemoimmunotherapy (ICI) with cemiplimab in combination with cisplatin and docetaxel (TPI) in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e18116
Abstract: e18116 Background: To enhance patients' quality of life and prolong their survival, exploring an effective, low-toxicity version of the induction regimen for LA SCCHN is crucial. The addition of immunotherapy to cisplatin and docetaxel (TP)… read more here.
Keywords: patients completed; scchn; cisplatin docetaxel; cemiplimab ... See more keywords
1112-P: Sustaining Show Rates in the Diabetes Clinic
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes"
DOI: 10.2337/db24-1112-p
Abstract: The Parkland Diabetes Clinic provides specialty diabetes care to the indigent people of Dallas County with diabetes. Previously, we showed that using an internally scheduling patients, rather than a third-party call center, and personally calling… read more here.
Keywords: show; show rates; patients completed; appointment ... See more keywords